Penny stocks refer to shares of companies that typically trade hands for less than $5. They are frequently associated with ...

Kura Oncology's (KURA) ziftomenib shows AML promise amid competition. See why I'm inclined to view the current price levels ...

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC ...

Spyre Therapeutics' innovative combination therapy approach targets multiple inflammatory pathways. Learn why SYRE stock is a Buy.

With this circuit, CEA-Leti demonstrated 4- and 16-point QAM, that increases the possible number of multiplexed devices by ...

Our recently implemented re-structuring and the re-prioritization of our clinical portfolio meaningfully extends our cash runway into late ...

H.C. Wainwright raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $70 from $69 and keeps a Buy rating on the shares following ...

Typically, you might invoke Task Manager when your PC is really chugging away and running very slowly, so you can see which ...

No matter the market environment, you’ll always find entertainment in the biotech space. There will always be biotech stocks ...

The Windows 11 beta update allows EU users to customize Lock Screen widgets freely This feature is solely available in the EU ...

In December 2024, Praxis received Rare Pediatric Disease Designation (RPDD) from the U.S. Food and Drug Administration (FDA) for relutrigine for Dravet Syndrome. This is the third RPDD for relutrigine ...

Cash and cash equivalents of $131.9M as of December 31, 2024 Cash runway extends through anticipated topline data readouts of COAST (early 2Q CY25) and ShORe (mid-CY25) MELBOURNE, Australia and ...